Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Neurotoxicity Research
Published in: Neurotoxicity Research 3/2015

01-10-2015 | Review

A Comprehensive View of the Neurotoxicity Mechanisms of Cocaine and Ethanol

Authors: Renato B. Pereira, Paula B. Andrade, Patrícia Valentão

Published in: Neurotoxicity Research | Issue 3/2015

Login to get access

Abstract

Substance use disorder is an emerging problem concerning to human health, causing severe side effects, including neurotoxicity. The use of illegal drugs and the misuse of prescription or over-the-counter drugs are growing in this century, being one of the major public health problems. Ethanol and cocaine are one of the most frequently used drugs and, according to the National Institute on Drug Abuse, their concurrent consumption is one of the major causes for emergency hospital room visits. These molecules act in the brain through different mechanisms, altering the nervous system function. Researchers have focused the attention not just in the mechanism of action of these drugs, but also in the mechanism by which they damage the nervous tissue (neurotoxicity). Therefore, the goal of the present review is to provide a global perspective about the mechanisms of the neurotoxicity of cocaine and ethanol.
Literature
Aggrawal A (1995) Cocaine: Gift from the Gods. Narcotic drugs. National Book Trust, New Delhi, pp 52–53
Ahn SM, Kim SW, Choe ES (2007) Cocaine increases immunoglobulin heavy chain binding protein and caspase-12 expression in the rat dorsal striatum. Psychopharmacology 195:407–414PubMedCrossRef
Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C (2010) Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 30:8285–8295PubMedCrossRef
Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ (2001) Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration. J Neurochem 79:221–224PubMedCrossRef
Apantaku-Olajide T, Darker CD, Smyth BP (2013) Onset of cocaine use: associated alcohol intoxication and psychosocial characteristics among adolescents in substance abuse treatment. J Addict Med 7:183–188PubMedCrossRef
Bailey SM, Cunningham CC (1998) Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. Hepatology 28:1318–1326PubMedCrossRef
Banerjee K, Munshi S, Sen O, Pramanik V, Roy MT, Chakrabarti S (2014) Dopamine cytotoxicity involves both oxidative and nonoxidative pathways in SH-SY5Y cells: potential role of alpha-synuclein overexpression and proteasomal inhibition in the etiopathogenesis of Parkinson’s disease. Parkinsons Dis 2014:1–12CrossRef
Binet F, Chiasson S, Girard D (2010) Evidence that endoplasmic reticulum (ER) stress and caspase-4 activation occur in human neutrophils. Biochem Biophys Res Commun 391:18–23PubMedCrossRef
Blanco AM, Vallés SL, Pascual M, Guerri C (2005) Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J Immunol 175:6893–6899PubMedCrossRef
Bodmer M, Enzler F, Liakoni E, Bruggisser M, Liechti ME (2014) Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: a case series. BMC Res Notes 7:1–7CrossRef
Borja-Oliveira CR (2014) Alcohol-medication interactions: the acetaldehyde syndrome. J Pharmacovigil 2:1000145
Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P, Roth RH (1993) Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 60:429–435CrossRef
Brassai A, Suvanjeiev RG, Bán EG, Lakatos M (2015) Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity. Brain Res Bull 112:1–6PubMedCrossRef
Butterworth RF, Kril JJ, Harper CG (1993) Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke–Korsakoff syndrome. Alcohol Clin Exp Res 17:1084–1088PubMedCrossRef
Cadet JL, Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117–131PubMedCrossRef
Cagienard F, Schulzki T, Reinhart WH (2014) Cocaine in high concentrations inhibits platelet aggregation in vitro. Clin Hemorheol Microcirc 57:385–394PubMed
Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, di Monte DA, Emson PC, Miller GW (2007) Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27:8138–8148PubMedCrossRef
Chaung WW, Jacob A, Ji Y, Wang P (2008) Suppression of PGC-1α by ethanol: implications of its role in alcohol induced liver injury. Int J Clin Exp Med 1:161–170PubMedPubMedCentral
Choe ES, Ahn SM, Yang JH, Go BS, Wang JQ (2011) Linking cocaine to endoplasmic reticulum in striatal neurons: role of glutamate receptors. Basal Ganglia 1:59–63PubMedPubMedCentral
Corsini GU, Zuddas A, Bonuccelli U, Schinelli S, Kopin IJ (1987) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde. Life Sci 40:827–832PubMedCrossRef
Costa BM, Yao H, Yang L, Buch S (2013) Role of endoplasmic reticulum (ER) stress in cocaine-induced microglial cell death. J Neuroimmune Pharmacol 8:705–714PubMedPubMedCentralCrossRef
Coutts DJ, Harrison NL (2015) Acetaldehyde, not ethanol, impairs myelin formation and viability in primary mouse oligodendrocytes. Alcohol Clin Exp Res 39:455–462PubMedCrossRef
Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59–69PubMedCrossRef
Cunha-Oliveira T, Rego AC, Morgadinho MT, Macedo T, Oliveira CR (2006) Differential cytotoxic responses of PC12 cells chronically exposed to psychostimulants or to hydrogen peroxide. Toxicology 217:54–62PubMedCrossRef
Cunha-Oliveira T, Rego AC, Oliveira CR (2008) Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 58:192–208PubMedCrossRef
Cunha-Oliveira T, Silva L, Silva AM, Moreno AJ, Oliveira CR, Santos MS (2013) Mitochondrial complex I dysfunction induced by cocaine and cocaine plus morphine in brain and liver mitochondria. Toxicol Lett 219:298–306PubMedCrossRef
Dai Q, Zhang J, Pruett SB (2005) Ethanol alters cellular activation and CD14 partitioning in lipid rafts. Biochem Biophys Res Commun 332:37–42PubMedCrossRef
Dawson P, Moffatt JD (2012) Cardiovascular toxicity of novel psychoactive drugs: lessons from the past. Prog Neuropsychopharmacol Biol Psychiatry 39:244–252PubMedCrossRef
Dean RA, Bosron WF, Zachman FM, Zhang J, Brzezinski MR (1997) Effects of ethanol on cocaine metabolism and disposition in the rat. NIDA Res Monogr 173:35–47PubMed
Dey S, Mactutus CF, Booze RM, Snow DM (2007) Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling. Neuroscience 144:509–521PubMedPubMedCentralCrossRef
Dhillon NK, Williams R, Peng F, Tsai YJ, Dhillon S, Nicolay B, Gadgil M, Kumar A, Buch SJ (2007) Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J Neurovirol 13:483–495PubMedCrossRef
Dietrich JB, Mangeol A, Revel MO, Burgun C, Aunis D, Zwiller J (2005) Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 48:965–974PubMedCrossRef
Duty S, Jenner P (2011) Animal models of Parkinson’s disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164:1357–1391PubMedPubMedCentralCrossRef
Echevarria DJ, Toms CN, Jouandot DJ (2011) Alcohol-induced behavior change in zebrafish models. Rev Neurosci 22:85–93PubMed
Enoksson M, Robertson JD, Gogvadze V, Bu P, Kropotov A, Zhivotovsky B, Orrenius S (2004) Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids. J Biol Chem 279:49575–49578PubMedCrossRef
Fleckenstein AE, Volz TJ, Hanson GR (2009) Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 56:133–138PubMedPubMedCentralCrossRef
Friedman WJ (2001) Cytokines regulate expression of the type I interleukin-1 receptor in rat hippocampal neurons and glia. Exp Neurol 168:23–31PubMedCrossRef
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G (2010) Mitochondrial gateways to cancer. Mol Asp Med 31:1–20CrossRef
Gandhi S, Vaarmann A, Yao Z, Duchen MR, Wood NW, Abramov AY (2012) Dopamine induced neurodegeneration in a PINK1 model of Parkinson’s disease. PLoS ONE 7:e37564PubMedPubMedCentralCrossRef
Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH (1993) Moderate alcohol intake, increased levels of high-density lipoprotein and its sub-fractions, and decreased risk of myocardial infarction. N Engl J Med 329:1829–1834PubMedCrossRef
Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci USA 104:18754–18759PubMedPubMedCentralCrossRef
Ghribi O, Herman MM, Spaulding NK, Savory J (2002) Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J Neurochem 82:137–145PubMedCrossRef
Giovannini MG, Scali C, Prosperi A, Belluci G, Pepeu G, Casamenti F (2003) Experimental brain inflammation and neurodegeneration as model of Alzheimer’s disease: protective effects of selective COX-2 inhibitors. Int J Immunopathol Pharmacol 16:31–40PubMed
Gluck MR, Zeevalk GD (2004) Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson’s disease and catecholamine-associated diseases. J Neurochem 91:788–795PubMedCrossRef
González-Hernández T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Pérez-Delgado M, Rodríguez M (2004) Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 479:198–215PubMedCrossRef
Gowrishankar R, Hahn MK, Blakely RD (2014) Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders. Neurochem Int 73:42–48PubMedCrossRef
Grewal SI, Moazed D (2003) Heterochromatin and epigenetic control of gene expression. Science 301:798–802PubMedCrossRef
Gveric D, Kaltschmidt C, Cuzner L, Newcombe J (1998) Transcription factor NFkB and inhibitor IkB are localized in macrophages in active Multiple Sclerosis lesions. J Neuropathol Exp Neurol 57:168–178PubMedCrossRef
Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D (2001) Diabetes mellitus and exocrine pancreatic dysfunction in perk −/− mice reveals a role for translational control in secretory cell survival. Mol Cell 7:1153–1163PubMedCrossRef
Harris DS, Everhart ET, Mendelson J, Jones RT (2003) The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 72:169–182PubMedCrossRef
Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC (1991a) Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 39:531–533PubMedCrossRef
Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC (1991b) Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 56:698–701PubMedCrossRef
Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson’s disease. Ann NY Acad Sci 991:214–228PubMedCrossRef
Horowitz JM, DiPirro JM, Kristal MB, Torres G (1997) Dopaminergic and glutamatergic mechanisms mediate the induction of FOS-like protein by cocaethylene. Brain Res Bull 42:393–398PubMedCrossRef
Hou H, Wang C, Jia S, Hu S, Tian M (2014) Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings. Neurosci Bull 30:765–776PubMedCrossRef
Huang WY, Vallés S, Qwarnstrom EE (2001) Translocation of the IL-1 receptor to focal adhesions is regulated through the C-terminal end of the cytoplasmic domain. Cell Biol Int 25:309–317PubMedCrossRef
Ivester P, Lide MJ, Cunningham CC (1995) Effect of chronic ethanol consumption on the energy state and structural stability of periportal and perivenous hepatocytes. Arch Biochem Biophys 322:14–21PubMedCrossRef
Iyer RN, Nobiletti JB, Jatlow PI, Bradberry CW (1995) Cocaine and cocaethylene: effects on extracellular dopamine in the primate. Psychopharmacology 120:150–155PubMedCrossRef
Jatlow P, McCance EF, Bradberry CW, Elsworth JD, Taylor JR, Roth RH (1996) Alcohol plus cocaine: the whole is more than the sum of its parts. Ther Drug Monit 18:460–464PubMedCrossRef
John GR, Lee SC, Brosnan CF (2003) Cytokines: powerful regulators of glial cell activation. Neuroscientist 9:10–22PubMedCrossRef
John GR, Lee SC, Song X, Rivieccio M, Brosnan CF (2005) IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 49:161–176PubMedCrossRef
Jung ME, Metzger DB (2015) Aberrant histone acetylation promotes mitochondrial respiratory suppression in the brain of alcoholic rats. J Pharmacol Exp Ther 352:258–266PubMedCrossRef
Kim TE, Lee EJ, Young JB, Shin DJ, Kim JH (2014) Wernicke encephalopathy and ethanol-related syndromes. Semin Ultrasound CT MR 35:85–96PubMedCrossRef
Ko HW, Park KY, Kim H, Han PL, Kim YU, Gwag BJ, Choi EJ (1998) Ca2+-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J Neurochem 71:1390–1395PubMedCrossRef
Kunitoh S, Imaoka S, Hiroi T, Yabusaki Y, Monna T, Funae Y (1997) Acetaldehyde as well as ethanol is metabolized by human CYP2E1. J Pharmacol Exp Ther 280:527–532PubMed
Lan YL, Zhao J, Li S (2014) Estrogen receptors’ neuroprotective effect against glutamate-induced neurotoxicity. Neurol Sci 35:1657–1662PubMedCrossRef
Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pflug Arch 460:525–542CrossRef
Le Foll B, Diaz J, Sokoloff P (2005) A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. NeuroReport 16:175–178PubMedCrossRef
Lee YW, Hennig B, Yao J, Toborek M (2001) Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res 66:583–591PubMedCrossRef
León-Velarde F, Huicho L, Monge C (1992) Effects of cocaine on oxygen consumption and mitochondrial respiration in normoxic and hypoxic mice. Life Sci 50:213–218PubMedCrossRef
Lepsch LB, Munhoz CD, Kawamoto EM, Yshii LM, Lima LS, Curi-Boaventura MF, Salgado TM, Curi R, Planeta CS, Scavone C (2009) Cocaine induces cell death and activates the transcription nuclear factor kappa-b in pc12 cells. Mol Brain 2:1–15CrossRef
Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S (2004) Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 90:1117–1131PubMedPubMedCentralCrossRef
Lieber CS (1998) Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment. J Stud Alcohol 59:9–25PubMedCrossRef
Lin TY, Huang WJ, Wu CC, Lu CW, Wang SJ (2014) Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats. PLoS ONE 9:e88644PubMedPubMedCentralCrossRef
Lipton JW, Gyawali S, Borys ED, Koprich JB, Ptaszny M, McGuire SO (2003) Prenatal cocaine administration increases glutathione and alpha-tocopherol oxidation in fetal rat brain. Brain Res Dev Brain Res 147:77–84PubMedCrossRef
Litosch I (2002) Novel mechanisms for feedback regulation of phospholipase C-beta activity. IUBMB Life 54:253–260PubMedCrossRef
Liu Z, Liu Y, Gao R, Li H, Dunn T, Wu P, Smith RG, Sarkar PS, Fang X (2014) Ethanol suppresses PGC-1α expression by interfering with the cAMP-CREB pathway in neuronal cells. PLoS ONE 9:e104247PubMedPubMedCentralCrossRef
Ma Y, Hendershot LM (2004) ER chaperone functions during normal and stress conditions. J Chem Neuroanat 28:51–65PubMedCrossRef
Macedo DS, de Vasconcelos SM, dos Santos RS, Aguiar LM, Lima VT, Viana GS, de Sousa FC (2005) Cocaine alters catalase activity in prefrontal cortex and striatum of mice. Neurosci Lett 387:53–56PubMedCrossRef
Marini AM, Jiang X, Wu X, Tian F, Zhu D, Okagaki P, Lipsky RH (2004) Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: from genes to phenotype. Restor Neurol Neurosci 22:121–130PubMed
Mark S, Gold MD (1993) The neurobiology of cocaine. cocaine. Springer, New York, pp 37–79
Martin PR, Singleton CK, Hiller-Sturmhofel S (2003) The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health 27:134–142PubMed
Martin BJ, Naughton BJ, Thirtamara-Rajamani K, Yoon DJ, Han DD, Devries AC, Gu HH (2011) Dopamine transporter inhibition is necessary for cocaine-induced increases in dendritic spine density in the nucleus accumbens. Synapse 65:490–496PubMedPubMedCentralCrossRef
Masaki T, Mochizuki H, Matsushita S, Yokoyama A, Kamakura K, Higuchi S (2004) Association of aldehyde dehydrogenase-2 polymorphism with alcoholic polyneuropathy in humans. Neurosci Lett 363:288–290PubMedCrossRef
Mastrogiacomo F, Bergeron C, Kish SJ (1993) Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer’s disease. J Neurochem 61:2007–2014PubMedCrossRef
Mattson MP, Meffert MK (2006) Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13:852–860PubMedCrossRef
McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI (1993) Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior and the role of cocaethylene. Psychopharmacology 11:39–46CrossRef
McCarthy DM, Zhang X, Darnell SB, Sangrey GR, Yanagawa Y, Sadri-Vakili G, Bhide PG (2011) Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain. J Neurosci 31:13400–13411PubMedPubMedCentralCrossRef
Mermelstein PG (2009) Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors. J Neuroendocrinol 21:257–262PubMedPubMedCentralCrossRef
Messing RO (2014) Alcohol and the nervous system. Aminoff’s neurology and general medicine, 5th edn. Academic Press, San Diego, pp 713–724CrossRef
Morris JA, Dorner AJ, Edwards CA, Hendershot LM, Kaufman RJ (1997) Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J Biol Chem 272:4327–4334PubMedCrossRef
Muriach M, López-Pedrajas R, Barcia JM, Sanchez-Villarejo MV, Almansa I, Romero FJ (2010) Cocaine causes memory and learning impairments in rats: involvement of nuclear factor kappa B and oxidative stress, and prevention by topiramate. J Neurochem 114:675–684PubMedCrossRef
Nnadi CU, Mimiko OA, McCurtis HL, Cadet JL (2005) Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc 97:1504–1515PubMedPubMedCentral
Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL, Kopajtic TA, Li CM, Amat J, Larson G, Cooper DC, Huang Y, O’Neill CE, Yin H, Zahniser NR, Katz JL, Rice KC, Maier SF, Bachtell RK, Watkins LR (2015) DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Mol Psychiatry. doi:10.​1038/​mp.​2014.​177 PubMed
Numa R, Kohen R, Poltyrev T, Yaka R (2008) Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 155:649–658PubMedCrossRef
O’Neill L (2000) The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans 28:557–563PubMedCrossRef
Olney JW, Tenkova T, Dikranian K, Muglia LJ, Jermakowicz WJ, D’Sa C, Roth KA (2002) Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis 9:205–219PubMedCrossRef
Pascual M, Blanco AM, Cauli O, Miñarro J, Guerri C (2007) Intermittent ethanol exposure induces inflammatory brain damage and causes long-term behavioural alterations in adolescent rats. Eur J Neurosci 25:541–550PubMedCrossRef
Pascual M, Boix J, Felipo V, Guerri C (2009) Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat. J Neurochem 108:920–931PubMedCrossRef
Patel M, Modig F, Magnusson M, Fransson PA (2010) Alcohol intoxication at 0.06 and 0.10% blood alcohol concentration changes segmental body movement coordination. Exp Brain Res 202:431–443PubMedCrossRef
Pereira DM, Valentão P, Correia-da-Silva G, Teixeira N, Andrade PB (2015) Translating endoplasmic reticulum biology into the clinic: a role for ER-targeted natural products? Nat Prod Rep. doi:10.​1039/​c4np00102h
Plush T, Shakespeare W, Jacobs D, Ladi L, Sethi S, Gasperino J (2015) Cocaine-induced agitated delirium: a case report and review. J Intensive Care Med 30:49–57PubMedCrossRef
Poon HF, Abdullah L, Mullan MA, Mullan MJ, Crawford FC (2007) Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells. Neurochem Int 50:69–73PubMedCrossRef
Qin W, Haroutunian V, Katsel P, Cardozo CP, Ho L, Buxbaum JD, Pasinetti GM (2009) PGC-1α expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 66:352–361PubMedPubMedCentralCrossRef
Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I (2012) Dopamine transporter imaging is associated with long-term outcomes in Parkinson’s disease. Mov Disord 27:1392–1397PubMedCrossRef
Ribeiro FM, Devries RA, Hamilton A, Guimarães IM, Cregan SP, Pires RG, Ferguson SS (2014) Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington’s disease. Hum Mol Genet 23:2030–2042PubMedCrossRef
Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319:1523–1528PubMedPubMedCentralCrossRef
Rindi G, Imarisio L, Patrini C (1986) Effects of acute and chronic ethanol administration on regional thiamin pyrophosphokinase activity of the rat brain. Biochem Pharmacol 35:3903–3908PubMedCrossRef
Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, Renthal W, Graham A, Birnbaum SG, Green TA, Robison B, Lesselyong A, Perrotti LI, Bolaños CA, Kumar A, Clark MS, Neumaier JF, Neve RL, Bhakar AL, Barker PA, Nestler EJ (2009) Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 29:3529–3537PubMedPubMedCentralCrossRef
Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999) NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5:554–559PubMedCrossRef
Schroeder FA, Penta KL, Matevossian A, Jones SR, Konradi C, Tapper AR, Akbarian S (2008) Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology 33:2981–2992PubMedPubMedCentralCrossRef
Sechi GP, Serra A (2007) Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6:442–455PubMedCrossRef
Sharma HS, Menon P, Lafuente JV, Muresanu DF, Tian ZR, Patnaik R, Sharma A (2014) Development of in vivo drug-induced neurotoxicity models. Expert Opin Drug Metab Toxicol 10:1637–1661PubMedCrossRef
Shen Y, Schlessinger K, Zhu X, Meffre E, Quimby F, Levy DE, Darnell JE (2004) Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 24:407–419PubMedPubMedCentralCrossRef
Shimoke K, Utsumi T, Kishi S, Nishimura M, Sasaya H, Kudo M, Ikeuchi T (2004) Prevention of endoplasmic reticulum stress induced cell death by brain-derived neurotrophic factor in cultured cerebral cortical neurons. Brain Res 1028:105–111PubMedCrossRef
Shin EH, Bian S, Shim YB, Rahman MA, Chung KT, Kim JY, Wang JQ, Choe ES (2007) Cocaine increases endoplasmic reticulum stress protein expression in striatal neurons. Neuroscience 145:621–630PubMedCrossRef
Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, Dawson TM (2011) PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson’s disease. Cell 144:689–702PubMedPubMedCentralCrossRef
Siddiqui WA, Ahad A, Ahsan H (2015) The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. Arch Toxicol 89:289–317PubMedCrossRef
Signorini-Allibe N, Gonthier B, Lamarche F, Eysseric H, Barret L (2005) Chronic consumption of ethanol leads to substantial cell damage in cultured rat astrocytes in conditions promoting acetaldehyde accumulation. Alcohol Alcohol 40:163–171PubMedCrossRef
Siniscalchi A, Bonci A, Mercuri NB, De Siena A, De Sarro G, Malferrari G, Diana M, Gallelli L (2015) Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res 12:163–172PubMedCrossRef
Sordo L, Indave BI, Barrio G, Degenhardt L, de la Fuente L, Bravo MJ (2014) Cocaine use and risk of stroke: a systematic review. Drug Alcohol Depend 142:1–13PubMedCrossRef
St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:397–408PubMedCrossRef
Surendran S, Rajasankar S (2010) Parkinson’s disease: oxidative stress and therapeutic approaches. Neurol Sci 31:531–540PubMedCrossRef
Takeuchi M, Saito T (2005) Cytotoxicity of acetaldehyde-derived advanced glycation end-products (AA-AGE) in alcoholic-induced neuronal degeneration. Alcohol Clin Exp Res 29:220S–224SPubMedCrossRef
Tallarida CS, Bires K, Avershal J, Tallarida RJ, Seo S, Rawls SM (2014) Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians. Alcohol 48:579–586PubMedPubMedCentralCrossRef
Tarragon E, Baliño P, Aragon CM (2014) Centrally formed acetaldehyde mediates ethanol-induced brain PKA activation. Neurosci Lett 580:68–73PubMedCrossRef
Tiwari V, Chopra K (2013) Resveratrol abrogates alcoholinduced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain. Neurochem Int 62:861–869PubMedCrossRef
Todd Wilk MD (2008) Manual of adolescent substance abuse treatment. American Psychiatric Publishing, Virginia, pp 44–45
Vidhya A, Renjugopal V, Indira M (2013) Impact of thiamine supplementation in the reversal of ethanol induced toxicity in rats. Indian J Physiol Pharmacol 57:406–417PubMed
Volkow ND, Kim SW, Wang GJ, Alexoff D, Logan J, Muench L, Shea C, Telang F, Fowler JS, Wong C, Benveniste H, Tomasi D (2013) Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain. Neuroimage 64:277–283PubMedPubMedCentralCrossRef
Yoon H, Kim DS, Lee GH, Kim KW, Kim HR, Chae HJ (2011a) Apoptosis induced by manganese on neuronal SK-N-MC cell line: endoplasmic reticulum (ER) stress and mitochondria dysfunction. Environ Health Toxicol 26:e2011017PubMedPubMedCentralCrossRef
Yoon H, Lee GH, Kim DS, Kim KW, Kim HR, Chae HJ (2011b) The effects of 3, 4 or 5 amino salicylic acids on manganese-induced neuronal death: ER stress and mitochondrial complexes. Toxicol In Vitro 25:1259–1268PubMedCrossRef
Ziedonis DM, Kosten TR (1991) Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psycoactive Drugs 23:417–425CrossRef
Zimatkin SM, Pronko SP, Vasiliou V, Gonzalez FJ, Deitrich RA (2006) Enzymatic mechanisms of ethanol oxidation in the brain. Alcohol Clin Exp Res 30:1500–1505PubMedCrossRef
Metadata
Title
A Comprehensive View of the Neurotoxicity Mechanisms of Cocaine and Ethanol
Authors
Renato B. Pereira
Paula B. Andrade
Patrícia Valentão
Publication date
01-10-2015
Publisher
Springer US
Published in
Neurotoxicity Research / Issue 3/2015
Print ISSN: 1029-8428
Electronic ISSN: 1476-3524
DOI
https://doi.org/10.1007/s12640-015-9536-x

Other articles of this Issue 3/2015

Neurotoxicity Research 3/2015 Go to the issue

Original Article

Role of Ryanodine and NMDA Receptors in Tetrabromobisphenol A-Induced Calcium Imbalance and Cytotoxicity in Primary Cultures of Rat Cerebellar Granule Cells

Original Article

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications

Original Article

Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP+)

Original Article

Cobalt-Induced Ototoxicity in Rat Postnatal Cochlear Organotypic Cultures

Review

Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder

Original Article

NMDA Receptors and Oxidative Stress Induced by the Major Metabolites Accumulating in HMG Lyase Deficiency Mediate Hypophosphorylation of Cytoskeletal Proteins in Brain From Adolescent Rats: Potential Mechanisms Contributing to the Neuropathology of This Disease